Detailed Information on Publication Record
2017
Non-Invasive Assessment of Vascular System Function and Damage Induced by Anthracycline Treatment in the Pediatric Cancer Survivors
BUDINSKAYA, Ksenia, Veronika PUCHNEROVÁ, Jana SVAČINOVÁ, Jan NOVÁK, Hana HRSTKOVÁ et. al.Basic information
Original name
Non-Invasive Assessment of Vascular System Function and Damage Induced by Anthracycline Treatment in the Pediatric Cancer Survivors
Authors
BUDINSKAYA, Ksenia (643 Russian Federation, belonging to the institution), Veronika PUCHNEROVÁ (203 Czech Republic, belonging to the institution), Jana SVAČINOVÁ (203 Czech Republic, guarantor, belonging to the institution), Jan NOVÁK (203 Czech Republic, belonging to the institution), Hana HRSTKOVÁ (203 Czech Republic, belonging to the institution), Marie NOVÁKOVÁ (203 Czech Republic, belonging to the institution), Anna PEKAŘOVÁ (203 Czech Republic, belonging to the institution), Matej PEKAŘ (703 Slovakia, belonging to the institution) and Zuzana NOVÁKOVÁ (203 Czech Republic, belonging to the institution)
Edition
Physiological Research, Praha, Fyziologický ústav AV ČR, 2017, 0862-8408
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30105 Physiology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.324
RIV identification code
RIV/00216224:14110/17:00099503
Organization unit
Faculty of Medicine
UT WoS
000422901400014
Keywords in English
Anthracyclines; Cardiotoxicity; Pulse wave velocity; Pulse wave analysis; Arterial stiffness
Tags
Tags
International impact, Reviewed
Změněno: 20/3/2018 17:02, Soňa Böhmová
Abstract
V originále
Anthracyclines represent one of the important classes of anti-cancer drugs; however, their major disadvantage is their profound cardiovascular toxicity. This study aimed to evaluate influence of anthracyclines on cardiovascular stiffness parameters estimated from pulse wave (PW). PW was measured in 59 cancer survivors treated with anthracyclines in childhood and in 248 healthy age-matched controls. Both patients and controls were divided into three age groups (13 – 15, 16 – 18 and 19 – 24 years). Central PW augmentation index (C-AI75) and augmentation pressure (C-AP75), both normalized to heart rate 75 bpm, were calculated as parameters of arterial wall stiffness. Central Buckberg sub-endocardial viability ratio (SEVR) was calculated as a parameter of diastolic function. Patients and controls were compared in each age group. C-AI75 and C-AP75 were significantly increased in patients in age groups 16 – 18 and 19 – 24 years. SEVR was decreased in patients in the oldest age group. Our results suggest that although toxic influence of anthracyclines to arterial wall and heart are developing during childhood and puberty, they can be detected rather in the adulthood. These changes are yet subclinical; however, their presence ndicates potentially increased cardiovascular risk in childhood cancer survivors treated with anthracyclines during childhood.
Links
MUNI/A/1355/2016, interní kód MU |
|